Antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products

  12 March 2021

The objective of the draft reflection paper is to review available information on the emissions and the environmental fate of veterinary medicinal products as sources of antimicrobial resistance (AMR) and antimicrobial resistant genes to and within the environment, and their risk to human and animal health. The document considers the suitability of the current risk assessment process for AMR and risk mitigation recommendations, and notes knowledge gaps and research needs.

Further reading: European Medicines Agency
Author(s): European Medicines Agency
Healthy Animals  


Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified

Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!